HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Clinical Relevance of Anti-DFS70 Autoantibodies.

Abstract
Despite all the progress in the establishment of specific autoantibody assays, screening for antinuclear antibodies (ANA) by indirect immunofluorescence on HEp-2 cells for quality-oriented laboratory diagnosis of ANA associated rheumatic diseases (AARD) remains indispensable but is not without limitations. Recent data on the relevance of the dense fine speckled (DFS) pattern and anti-DFS70 antibodies disclosed novel possibilities to optimize the serological stepwise diagnostics of AARD. The DFS pattern on HEp-2 cells is well differentiated from the classic "homogeneous" ANA pattern associated with dsDNA antibodies. This is the most frequent pattern in high titer ANA-positive healthy persons. The most characteristic ANA specificity associated with DFS pattern is the anti-DFS70 antibody (synonym LEDGF antibody). The prevalence of anti-DFS70 antibodies in AARD patients is significantly lower compared with the prevalence in ANA-positive healthy persons. There is a negative association between anti-DFS70 antibodies and AARD, especially if no concomitant AARD-specific autoantibodies are found. Isolated anti-DFS70 antibodies are detectable in less than 1 % of AARD but are detectable in 2-22 % of healthy persons. In the presence of an isolated anti-DFS70 antibody, the posttest probability for AARD is reduced significantly. The significance of anti-DFS70 antibodies as a criterion that helps to exclude AARD is also confirmed by follow-up studies on anti-DFS70 antibodies of positive, healthy individuals, who did not develop any AARD during a 4 year observation period. Consequently, anti-DFS70 antibodies are valuable novel biomarkers for better interpretation of positive ANA in cases of negative AARD-associated autoantibodies and should be integrated in modified test algorithms to avoid unnecessary referrals and examinations of ANA-positive persons.
AuthorsKarsten Conrad, Nadja Röber, Luis E C Andrade, Michael Mahler
JournalClinical reviews in allergy & immunology (Clin Rev Allergy Immunol) Vol. 52 Issue 2 Pg. 202-216 (Apr 2017) ISSN: 1559-0267 [Electronic] United States
PMID27350273 (Publication Type: Journal Article, Review)
Chemical References
  • Adaptor Proteins, Signal Transducing
  • Antibodies, Antinuclear
  • Autoantibodies
  • Autoantigens
  • Biomarkers
  • PSIP1 protein, human
  • Transcription Factors
Topics
  • Adaptor Proteins, Signal Transducing (immunology)
  • Antibodies, Antinuclear (immunology)
  • Autoantibodies (immunology)
  • Autoantigens (immunology)
  • Autoimmune Diseases (diagnosis, immunology)
  • Biomarkers (analysis)
  • Humans
  • Transcription Factors (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: